Global Presence


The company has a presence in more than 25 countries across North and South America, Europe, Asia, Middle and Far East and Africa.

World Medicine enjoys a unique position in the countries of presence because of its know-how in marketing and highly professional sales and marketing teams who are the core power of our competitiveness and guarantee of our success.

The company has identified Regulated markets comprising North and South America, Europe, Asia, Middle and Far East and Africa, as one of its major drivers for growth in the coming years.

World Medicine is in the process of establishing an extensive marketing, distribution and pharmacy chain network in all the countries of presence and the company pays more attention to expand its product portfolio via registration and launch of novel pharmaceutical products.

We need long-term objectives , profound understanding of the competitive environment, objective appraisal of resources and succesful implementation.

A significant share of the company’s revenues come from international operations, and several major brands like Cocarnit (a mixed metabolic product), Ulsepan (pantoprazole) and anti-infectives like Bactamed (ampicillin/sulbactam), Cefamed (ceftriaxone), Levoximed (levofloxacin) are widely recognized in the countries of presence.